The rising prevalence of chronic diseases is one of the major factors propelling the demand for lancets across the world. There has been a huge increase in the occurrence rate of chronic obstructive pulmonary disease (COPD), diabetes, cardiovascular diseases (CVDs), and cancer across the globe over the last few years and this has considerably boosted the need for minimally invasive blood-drawing medical devices such as lancets. According to the World Health Organization (WHO), more than 235 million people around the world are suffering from asthma and 3 million deaths are caused each year, due to COPD.
The increasing prevalence of infections and injuries due to the use of needle sticks is another important factor fuelling the rise in the demand for lancets across the globe. Due to these factors, the global lancet market generated revenue of $830.3 million in 2019 and is expected to exhibit a CAGR of 9.5% during the forecast period (2020–2030). Lancets are being widely adopted in diagnostic centers, hospitals and clinics, and homecare settings throughout the world. Amongst these, the hospitals and clinics are predicted to observe the highest growth in the adoption of lancets during the forecast period.Thus, it
can be concluded that due to the rising incidence of chronic diseases
especially diabetes and the ballooning popularity of minimally invasive blood
drawing medical devices, the demand for lancets will rise significantly across
the world, over the next few years.
No comments:
Post a Comment